Del Mar, CA, United States of America

Fred Levine

This inventor holds 9 USPTO granted patents and 3 published patent applications. Top assignees: University of California, Burnham Institute for Medical Research, The Whittier Institute for Diabetes & Endocrinology. Active years: 1998-2012.

USPTO Granted Patents = 9 

% Patents Active = 33.3

Average Co-Inventor Count = 2.2

ph-index = 4

Forward Citations = 66(Granted Patents)


Company Filing History:


Years Active: 1998-2012

Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Journey of Fred Levine

Introduction: Fred Levine, a visionary inventor based in Del Mar, California, has made significant contributions to the world of innovations with his creative mind and relentless pursuit of excellence.

Latest Patents: Fred Levine holds several patents in various fields, including technology, healthcare, and consumer products. His most recent patents focus on sustainable energy solutions and smart home devices, showcasing his versatility and forward-thinking approach.

Career Highlights: With a career spanning over two decades, Fred Levine has established himself as a prominent figure in the innovation industry. He has successfully brought numerous groundbreaking ideas to life, revolutionizing the way we interact with technology and the world around us.

Collaborations: Throughout his career, Fred Levine has collaborated with leading tech companies, research institutions, and universities to further his inventions. His ability to work seamlessly with experts from diverse backgrounds has led to the development of cutting-edge technologies with real-world applications.

Conclusion: Fred Levine's passion for innovation, coupled with his dedication to pushing the boundaries of what is possible, continues to inspire the next generation of inventors. His impact on the industry is undeniable, and his legacy will undoubtedly shape the future of technology for years to come.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…